Home / Services / Safety and general pharmacology
Safety pharmacology end-points are also available in regulatory toxicity studies using animals (dog, non-human primate and mini-pig) via specific approaches dedicated to the assessment of cardiovascular and respiratory functions by external telemetry and minimally invasive telemetry combined with Functional Observational Battery. With a wealth of experience in pharmacology and toxicology, CIT can be considered as the ideal partner for in vivo screening tests, as well as pathological, mutant and transgenic models. In the recent years, pathological models have been developed in a wide range of species and our expertise enables us to develop customized chronic pathology in vivo models.
1. ICH S7A – Core Battery Studies (CNS)
Central Nervous system
Cardiovascular system (CV)
Respiratory systemWhole body plethysmography in conscious rats and guinea-pigs
2. ICH S7A - Supplemental studies
Renal function
Gastro-intestinal system
Endocrine system
Coagulation
3. ICH S7B - QT Prolongation and Arrhythmogenic ProfileIn vivo
In vitro
Available under GLP conditions through partnerships
4. Safety pharmacology endpoints in toxicologyCentral nervous system
Cardiovascular system (CV)
Respiratory system
Combining the evaluation of three functions in regulatory toxicology
5. Early safety pharmacology screening battery for QT lengthening and Cardiovascular toxicity assessment In vivo
In vitro
6. Other pharmacological tests
General Pharmacology
Disease models
Juvenile models
|

|
|
|
© All rights reserved to CIT | Conception 2exVia with MasterEdit©